Monday, August 31, 2020 7:03:36 PM
While many lost patience and others sold from fear, I was preparing my accounts for this moment for quite some time.
I have been studying PACV and their stock for almost 2 years and I believe we are getting ready to see some interesting events unfold rather soon.
I am not certain what the fear of losing assets to TCA is all about here. When a lender goes under, the debts and agreements are transferred to new lenders. Its rather simple. Like a home mortgage. If your lender goes out of business, a new lender is assigned and you continue making the payments under the same agreement to the new lender. Your home does not default to that lender because THEY went out of business for whatever reason.
Like PACV, their assets are only at risk if they do NOT pay the debts they originally agreed to pay. The only difference now that their lender, TCA, is in trouble. Not PACV.. With a TCA receiver, negotiation on a lower lump settlement is much more appealing to both parties. Otherwise, PACV will continue their payments as agreed upon to a new lender, and the documents will transfer too.
Why is the team not mentioning this topic?
I believe a new lender is being scouted and the update will be all-inclusive in regards; considering the priority of this topic, a PR should be dedicated.
PACV and the .80 range. Volume is picking up. Interesting trade activity past few days. Eyes peeled..
Recent PACV News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 06:14:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/21/2023 02:43:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 09:24:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/25/2023 10:05:25 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/18/2023 04:47:41 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 07/19/2023 07:37:48 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 06/29/2023 10:15:09 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM